Aortyx announced today that it brought in $16 million (€13.8 million) to support its bioresorbable aortic patch technology.

To assess the effects of left ventricular (LV) load on isovolumic relaxation rate of the hypertrophied LV, wide range LV load shifts were imposed by the sequential use of balloon aortic valvuloplasty ...